Browse Category

Stock Market News 9 January 2026

Almonty Industries stock drops after lock-up ends; traders look to March earnings date

Almonty Industries stock drops after lock-up ends; traders look to March earnings date

Toronto, January 9, 2026, 13:01 EST — Regular session Almonty Industries Inc shares fell 6.8% to C$12.01 in Toronto by around 1 p.m. EST, while the miner’s Nasdaq-listed stock was down 7.8% at $8.58. The stock has traded between C$12.01 and C$12.94 on the day, after closing at C$12.88 on Thursday. (Investing.com) The drop comes a day after a short “lock-up” expired, according to S&P Capital IQ data. A lock-up is an agreement that stops certain holders from selling shares for a set period after a stock sale, and the note said the restriction ran from Dec. 9 to Jan.
Citigroup stock ticks up as CPI, Citi earnings set next test

Citigroup stock ticks up as CPI, Citi earnings set next test

New York, January 9, 2026, 12:49 (ET) — Regular session Citigroup shares were up 0.8% at $121.53 on Friday, with investors leaning into the start of U.S. bank earnings season next week and a key inflation report that could shift rate bets. Stocks have opened 2026 calmly, but strategists say the quiet could break as earnings and macro data hit. “As we’re starting January, the market may be underappreciating some of the events on the horizon,” Michael Arone, chief investment strategist at State Street Investment Management, said. (Reuters) The bank reports start with JPMorgan on Jan. 13, followed by Citigroup,
Why Immunome stock is up today: IMNM jumps 7% as biotech firms up and JPM conference looms

Why Immunome stock is up today: IMNM jumps 7% as biotech firms up and JPM conference looms

New York, January 9, 2026, 13:01 EST — Regular session Immunome, Inc. shares jumped on Friday, outpacing a firmer biotech tape. The Nasdaq-listed stock (IMNM) was up 7.4% at $21.97, after trading between $20.71 and $22.00. The move keeps attention on Immunome’s lead drug, varegacestat, being developed for desmoid tumors — non-cancerous growths in connective tissue that can still be painful and hard to treat. The company has said it plans to file a New Drug Application (NDA) with the U.S. Food and Drug Administration in the second quarter of 2026; an NDA is the formal request for approval to
Lumentum stock slips in choppy trade as Wall Street lifts targets to $455-$470

Lumentum stock slips in choppy trade as Wall Street lifts targets to $455-$470

New York, Jan 9, 2026, 13:01 EST — Regular session Shares of Lumentum Holdings Inc (LITE) were down 2.4% at $339.88 by early afternoon on Friday, pulling back after a violent week for the optical components maker. The stock has traded between $334.01 and $362.63 so far, with about 3.7 million shares changing hands. The move matters now because Lumentum sits in the plumbing of artificial intelligence (AI) data centers, selling lasers and optical parts that push data as light, not electricity. After a sharp run, traders have treated the name like a referendum on cloud spending and networking upgrades.
SoundHound AI stock jumps 9% as CES 2026 headlines collide with a fresh DA Davidson target cut

SoundHound AI stock jumps 9% as CES 2026 headlines collide with a fresh DA Davidson target cut

New York, Jan 9, 2026, 12:45 EST — Regular session Shares of SoundHound AI Inc (SOUN) were up about 9% at $12.01 in midday trading on Friday after hitting an intraday high of $12.305. The stock traded as low as $11.15, with about 27.5 million shares changing hands. The move follows a choppy stretch for the voice-AI company after brokerage D.A. Davidson cut its price target to $14 from $17 while keeping a “buy” rating, according to a Reuters Breakingviews “BUZZ” item. The broker said SoundHound’s go-to-market plans — its sales rollout — look more complex than expected, which could
Why Regencell Bioscience (RGC) stock is moving today: choppy rebound after Nasdaq pauses

Why Regencell Bioscience (RGC) stock is moving today: choppy rebound after Nasdaq pauses

NEW YORK, Jan 9, 2026, 12:43 EST — Regular session Regencell Bioscience Holdings Limited shares rose about 8.5% to $44.96 in midday trading on Friday, clawing back from an early dip. The stock has swung between $35.13 and $50.92 in the session, with more than 1.1 million shares traded. The bounce keeps attention on RGC after a stretch of sharp moves that has been hard to pin on fresh company updates. Regencell’s investor-relations site shows its most recent press release was dated Oct. 31. (Regencell Bioscience –) Thursday was a reminder of how quickly the shares can turn: they ended
Goldman Sachs stock edges up after Apple Card exit adds $0.46 to Q4 EPS — what to watch next

Goldman Sachs stock edges up after Apple Card exit adds $0.46 to Q4 EPS — what to watch next

New York, January 9, 2026, 12:57 ET — Regular session Goldman Sachs shares nudged up Friday after the bank said it has a deal to move the Apple Card program to JPMorgan Chase’s Chase, which JPMorgan and Apple said would shift more than $20 billion in card balances to Chase once the transition is finished. Goldman was up 0.5% at $939.12 by midday, versus a 0.1% gain for the Financial Select Sector SPDR ETF; JPMorgan and Morgan Stanley also traded higher. Goldman said the exit should lift fourth-quarter diluted earnings per share by about 46 cents, reflecting a $2.48 billion
Builders FirstSource (BLDR) stock jumps as Trump’s $200B mortgage-bond order jolts housing names

Builders FirstSource (BLDR) stock jumps as Trump’s $200B mortgage-bond order jolts housing names

New York, January 9, 2026, 12:48 (EST) — Regular session Builders FirstSource shares jumped 10.8% to $123.27 in midday trading, as investors chased housing-linked stocks after President Donald Trump ordered a $200 billion purchase of mortgage bonds. The trade is simple: cheaper mortgages can pull buyers back in. For a supplier tied to new-home construction and repair work, even a small shift in demand can swing volumes and margins. It also lands at a jittery moment for anything rate-sensitive. Investors have been punishing housing names on affordability worries, then snapping them up on any hint that borrowing costs might ease.
Home Depot stock jumps nearly 4% as Trump’s mortgage-bond order lifts housing plays

Home Depot stock jumps nearly 4% as Trump’s mortgage-bond order lifts housing plays

NEW YORK, Jan 9, 2026, 12:40 PM EST — Regular session Home Depot shares rose about 4% in midday trading on Friday as investors bought housing-linked names after President Donald Trump ordered mortgage agencies Fannie Mae and Freddie Mac to purchase $200 billion of mortgage-backed securities, bonds backed by pools of home loans. The stock was up 4.1% at $374.25. Redfin economist Chen Zhao called the plan’s impact “fairly small” and pegged any drop in mortgage rates at 10 to 15 basis points, or 0.10 to 0.15 percentage point. (Reuters) The stock is sensitive to the same forces pressuring the
Hawaiian Electric stock jumps toward $15 after BlackRock stake filing and Maui wildfire settlement update

Hawaiian Electric stock jumps toward $15 after BlackRock stake filing and Maui wildfire settlement update

New York, Jan 9, 2026, 12:37 EST — Regular session Hawaiian Electric Industries Inc shares were up about 9% at $14.91 in midday New York trading on Friday, after touching $15.04 earlier in the session. The stock opened at $13.66 and has traded nearly 3.0 million shares so far, market data showed. The Honolulu-based utility parent has been a legal headline stock since the 2023 Maui wildfires, and traders still price the equity around how big the liability bill could be and how long it takes to pin it down. A clearer path to settlements can shrink the range of
AppLovin Corporation stock jumps as Wells Fargo lifts target ahead of Feb. 11 earnings

AppLovin Corporation stock jumps as Wells Fargo lifts target ahead of Feb. 11 earnings

NEW YORK, Jan 9, 2026, 12:38 EST — Regular trading AppLovin shares gained 4.4% on Friday after Wells Fargo raised its price target on the advertising software company, leaving the stock far out in front of a broader tech bounce. The stock added $26.91 to $643.44, after trading in a $612.65 to $649.51 range; the Invesco QQQ Trust was up about 0.9% and the SPDR S&P 500 ETF was up about 0.7%. Wells Fargo analyst Alec Brondolo lifted his price target to $735 from $721 and reiterated an Overweight rating, a sign the bank sees the stock beating its peers.
RTX stock rises as Trump buyback curb clouds defense payouts, $1.5T budget talk lingers

RTX stock rises as Trump buyback curb clouds defense payouts, $1.5T budget talk lingers

New York, January 9, 2026, 12:44 (EST) — Regular session RTX Corp shares rose 0.8% to $188.70 in midday trading on Friday, after moving between $184.51 and $189.16 earlier in the session. The defense and aerospace group has been volatile this week as Washington signaled a tougher line on contractor performance and shareholder payouts. The stock’s bounce came as investors digested President Donald Trump’s executive order that ties dividends, share buybacks and executive incentive pay to weapons delivery schedules, prompting contractors to seek legal advice, three sources told Reuters. The order lays out a 30-day window for the Pentagon to

Stock Market Today

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop